BSETransgene Biotek LtdHighNegative
Announced Fri, 17 Oct · 12:47 IST

Declaration under clause 36

Regulatory & Legal View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Transgene Biotek has informed the stock exchange that Babaji Nethralayya Pvt Ltd has filed a case against the company at the NCLT (Hyderabad) bench over an unpaid loan of Rs. 6,82,05,834 (approximately Rs. 6.82 crores) along with interest and other charges. The matter was listed for hearing on October 16, 2025, and has been adjourned to December 16, 2025. The company has stated it is making efforts to resolve the dispute amicably. The filing was made under Clause 36 of the listing agreement with BSE.

Likely market impact

This signals rising financial and legal stress for the company, as a creditor has taken the unpaid loan dispute to the NCLT, which could escalate into insolvency proceedings if not resolved. Shareholders should watch for the next hearing on December 16, 2025, as the outcome could materially affect the stock and the company's liquidity position.